Latest Regulatory News

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.

InhaleRX Limited has announced a non-renounceable entitlement offer to raise approximately $247,668 by issuing nearly 10 million new shares at 2.5 cents each, accompanied by free attaching options. The offer opens on 5 December and closes on 17 December 2025.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

Fulcrum Lithium has secured 201 claims in Nevada’s Lander County, revealing surface lithium grades up to 1,219 ppm and setting the stage for a maiden drilling campaign in early 2026.

PainChek Ltd has secured FDA De Novo clearance for its Adult App, marking a pivotal entry into the US long-term care market and setting the stage for global expansion including its Infant App.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Santa Fe Minerals Limited has agreed to acquire an 80% stake in four promising gold projects in Côte d’Ivoire, backed by a $6 million placement to accelerate exploration. The deal significantly broadens Santa Fe’s presence in a prolific West African gold region.

Santa Fe Minerals has struck a binding deal to acquire an 80% stake in four gold projects in Côte d’Ivoire, backed by a $6 million placement. The acquisition expands its footprint in West Africa’s prolific gold belt, offering a robust pipeline from early-stage prospects to drill-ready targets.

Invictus Energy updates progress on its AMOG joint venture with Al Mansour Holdings, revealing ongoing negotiations for a significant Qatari ownership stake and deferral of a key placement settlement.

Race Oncology has received ethics approval to launch its HARNESS-1 Phase 1a/b trial testing RC220 combined with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward addressing resistance to current therapies.

Whitefield Income Limited has successfully completed a $52.9 million placement to wholesale investors, issuing over 40 million new shares amid strong demand. The capital raise leverages the company’s full placement capacity without requiring shareholder approval.